These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24358214)

  • 61. India's pharmaceutical industry: hype or high tech take-off?
    Malhotra P; Lofgren H
    Aust Health Rev; 2004 Nov; 28(2):182-93. PubMed ID: 15527398
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Dismantling of "Big Pharma" gives new impetus to the pharmaceutical sector. Dynamic life science clusters can increase Swedish competitiveness].
    Hedner T; Gatenbeck L
    Lakartidningen; 2012 Jun 27-Jul 17; 109(26-28):1280-1. PubMed ID: 22852257
    [No Abstract]   [Full Text] [Related]  

  • 63. Macro trends in pharmaceutical innovation.
    Cohen FJ
    Nat Rev Drug Discov; 2005 Jan; 4(1):78-84. PubMed ID: 15688075
    [TBL] [Abstract][Full Text] [Related]  

  • 64. How to create innovation by building the translation bridge from basic research into medicinal drugs: an industrial perspective.
    Germann PG; Schuhmacher A; Harrison J; Law R; Haug K; Wong G
    Hum Genomics; 2013 Mar; 7(1):5. PubMed ID: 23496921
    [TBL] [Abstract][Full Text] [Related]  

  • 65. American export control, technology spillover and innovation of Chinese pharmaceutical Industry.
    Hui J
    Pak J Pharm Sci; 2017 May; 30(3(Special)):1151-1155. PubMed ID: 28671099
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A new patent-based approach for technology mapping in the pharmaceutical domain.
    Russo D; Montecchi T; Carrara P
    Pharm Pat Anal; 2013 Sep; 2(5):611-27. PubMed ID: 24237169
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Are patents impeding medical care and innovation?
    Gold ER; Kaplan W; Orbinski J; Harland-Logan S; N-Marandi S
    PLoS Med; 2010 Jan; 7(1):e1000208. PubMed ID: 20052274
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Plant cell culture technology in the cosmetics and food industries: current state and future trends.
    Eibl R; Meier P; Stutz I; Schildberger D; Hühn T; Eibl D
    Appl Microbiol Biotechnol; 2018 Oct; 102(20):8661-8675. PubMed ID: 30099571
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Patenting nanotechnology.
    Lemley MA
    Stanford Law Rev; 2005 Nov; 58(2):601-30. PubMed ID: 16395838
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Patentees research and development expenditure in Canada.
    Li S; Tomalin A
    J Pharm Pharm Sci; 2002; 5(1):5-11. PubMed ID: 12042113
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Analysis of patent innovation in the field of brachytherapy.
    Miljanic M; Prabhu AV; Patel M; Lewis GD; Kim T
    Brachytherapy; 2020; 19(4):510-517. PubMed ID: 32249181
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Data science tools and applications on the way to Pharma 4.0.
    Steinwandter V; Borchert D; Herwig C
    Drug Discov Today; 2019 Sep; 24(9):1795-1805. PubMed ID: 31207205
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Potential effects of increased openness in pharma: the original knowledge behind new drugs.
    Bignami F; Mattsson P
    Drug Discov Today; 2019 Oct; 24(10):1957-1962. PubMed ID: 31254489
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Are the economics of pharmaceutical research and development changing?: productivity, patents and political pressures.
    Grabowski H
    Pharmacoeconomics; 2004; 22(2 Suppl 2):15-24. PubMed ID: 15660474
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The publishing and patenting strategies of successful university spinoffs in the biopharmaceutical industry.
    Erden Z
    Drug Discov Today; 2017 Jan; 22(1):5-9. PubMed ID: 27634342
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Utilization of text mining as a big data analysis tool for food science and nutrition.
    Tao D; Yang P; Feng H
    Compr Rev Food Sci Food Saf; 2020 Mar; 19(2):875-894. PubMed ID: 33325182
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ask the experts: future of the pharmaceutical industry. Interview by Future Medicinal Chemistry.
    Cottens S; Eaton M; Fuhr J; Geary S; Johnson DS; Li G; Raveglia L; Robertson GM; Westwell A
    Future Med Chem; 2011 Nov; 3(15):1863-72. PubMed ID: 22023030
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Innovation in pharmaceutical and health biotechnology industries: challenges for a virtuous agenda].
    Vargas M; Gadelha CA; Costa LS; Maldonado J
    Rev Saude Publica; 2012 Dec; 46 Suppl 1():37-40. PubMed ID: 23532311
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The impact of external innovation on new drug approvals: A retrospective analysis.
    Liu X; Thomas CE; Felder CC
    Int J Pharm; 2019 May; 563():273-281. PubMed ID: 30664998
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Genetic patent protection in the pharmaceutical and biotechnology industries.
    Nunnally AC; Webster CJ; Brown SA; Cohen GA
    Community Genet; 2005; 8(4):209-16. PubMed ID: 16244474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.